Results 1 to 10 of about 30,157 (233)

Consumer preferences for the development of new emulsion products based on vegetable and animal fats. [PDF]

open access: yesPLoS One
Kowalska M   +5 more
europepmc   +1 more source

Essays in Pharmaceutical Economics

open access: yes, 2015
This doctoral dissertation incorporates formal industrial organization and mechanism design analysis in the pharmaceutical industry in order to expand our understanding of modern pharmaceutical markets and provide new insights to key policy questions. The focus is primarily on the supply side of the pharmaceutical sector and in particular on questions ...
openaire   +1 more source

Politicised Changes to the NICE Threshold Risk Making Cost-Effectiveness Analysis Performative, Not Informative. [PDF]

open access: yesAppl Health Econ Health Policy
Vallejo-Torres L   +7 more
europepmc   +1 more source

Regional Differences, Distributional Dynamics and Spatial Convergence of Pharmacist Human Resources in China: A Healthcare Tiers Difference Perspective

open access: yesRisk Management and Healthcare Policy
Bo Ding,1 Run Zhao,2 Xinyi Yue,2 Dexun Li2 1Pharmacy Department, Hefei Maternal and Child Health Hospital, Hefei, People’s Republic of China; 2School of Pharmaceutical Economics and Management, Anhui University of Chinese Medicine, Hefei, People’s ...
Ding B, Zhao R, Yue X, Li D
doaj  

Economic Markets and Pharmaceutical Innovation

open access: yesJournal of Economic Perspectives
Pharmaceutical innovations reach the market after a long and risky process that requires large, fixed, and sunk investments. Governments provide incentives for firms to make these investments through various forms of intellectual property protection that attempt to provide a return on capital for investors.
openaire   +1 more source

Home - About - Disclaimer - Privacy